摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

dihydroaustamide

中文名称
——
中文别名
——
英文名称
dihydroaustamide
英文别名
(3R,9S,11S)-12,12-dimethylspiro[1,7-diazatricyclo[7.5.0.03,7]tetradec-13-ene-11,2'-1H-indole]-2,3',8-trione
dihydroaustamide化学式
CAS
——
化学式
C21H23N3O3
mdl
——
分子量
365.432
InChiKey
IBKVDWUJGBOZEF-VWKPWSFCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    27
  • 可旋转键数:
    0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    69.7
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    dihydroaustamide氧气过氧化苯甲酰 作用下, 以 四氢呋喃 为溶剂, 反应 18.0h, 生成
    参考文献:
    名称:
    A Short Synthetic Route to (+)-Austamide, (+)-Deoxyisoaustamide, and (+)-Hydratoaustamide from a Common Precursor by a Novel Palladium-Mediated Indole → Dihydroindoloazocine Cyclization
    摘要:
    The first synthesis of (+)-austamide (1), (+)-deoxyisoaustamide (2), and (+)-hydratoaustamide (10) by a very direct route is described (Scheme 1). Starting from tryptophan methyl ester (3) intermediate 5 is generated in two steps in >98% overall yield. The key step in the synthesis is a novel cyclization of 5 involving organopalladium intermediates which gives the dihydroazocine 6. From this key intermediate the target structures are accessible in just a few steps as shown in Scheme 1. The remarkable conversion of 5 --> 6 can be rationalized by the mechanistic pathway shown in Scheme 2 that involves a multistep sequence which includes palladation, cyclization, and rearrangement.
    DOI:
    10.1021/ja026663t
  • 作为产物:
    描述:
    3-甲基-2-丁烯醛 在 palladium diacetate 、 sodium tetrahydroborate 、 氧气sodium methylate溶剂黄146间氯过氧苯甲酸 作用下, 以 四氢呋喃甲醇二氯甲烷 为溶剂, 23.0 ℃ 、101.33 kPa 条件下, 反应 6.25h, 生成 dihydroaustamide
    参考文献:
    名称:
    A Short Synthetic Route to (+)-Austamide, (+)-Deoxyisoaustamide, and (+)-Hydratoaustamide from a Common Precursor by a Novel Palladium-Mediated Indole → Dihydroindoloazocine Cyclization
    摘要:
    The first synthesis of (+)-austamide (1), (+)-deoxyisoaustamide (2), and (+)-hydratoaustamide (10) by a very direct route is described (Scheme 1). Starting from tryptophan methyl ester (3) intermediate 5 is generated in two steps in >98% overall yield. The key step in the synthesis is a novel cyclization of 5 involving organopalladium intermediates which gives the dihydroazocine 6. From this key intermediate the target structures are accessible in just a few steps as shown in Scheme 1. The remarkable conversion of 5 --> 6 can be rationalized by the mechanistic pathway shown in Scheme 2 that involves a multistep sequence which includes palladation, cyclization, and rearrangement.
    DOI:
    10.1021/ja026663t
点击查看最新优质反应信息

文献信息

  • A Short Synthetic Route to (+)-Austamide, (+)-Deoxyisoaustamide, and (+)-Hydratoaustamide from a Common Precursor by a Novel Palladium-Mediated Indole → Dihydroindoloazocine Cyclization
    作者:Phil S. Baran、E. J. Corey
    DOI:10.1021/ja026663t
    日期:2002.7.1
    The first synthesis of (+)-austamide (1), (+)-deoxyisoaustamide (2), and (+)-hydratoaustamide (10) by a very direct route is described (Scheme 1). Starting from tryptophan methyl ester (3) intermediate 5 is generated in two steps in >98% overall yield. The key step in the synthesis is a novel cyclization of 5 involving organopalladium intermediates which gives the dihydroazocine 6. From this key intermediate the target structures are accessible in just a few steps as shown in Scheme 1. The remarkable conversion of 5 --> 6 can be rationalized by the mechanistic pathway shown in Scheme 2 that involves a multistep sequence which includes palladation, cyclization, and rearrangement.
查看更多

同类化合物

米氮平溴化物 米氮平半水合物 米氮平-d3 米氮平 去甲米氮平-D4盐酸盐 去甲基米氮平 2-甲基-1,2,3,4,10,14B-六氢吡嗪并[2,1-a]吡啶并[2,3-C][2]苯并氮杂卓2-氧化物 10-氧代米氮平 1-氧代米氮平 1,2,3,4,10,14b-六氢-2-甲基-吡嗪并[2,1-a]吡啶并[2,3-c][2]苯并氮杂卓-8-醇 (S)-1,2,3,4,10,14b-六氢-2-甲基吡嗪并[2,1-a]吡啶并[2,3-c][2]苯并氮杂卓 (R)-1,2,3,4,10,14b-六氢-2-甲基吡嗪并(2,1-a)吡啶并(2,3-c)(2)苯并氮杂卓 dihydroaustamide (+)-austamide mirtazapine hydrate S-mirtazapine fumarate (+)-hydroaustamide (-)-N-Desmethyl-Mirtazapine (14bR)-2-(2-Phthalimidoethyl)-1,2,3,4,10,14b-hexahydropyrazino [2,1-a]pyrido[2,3-c][2]benzoazepine 1,2,3,4,10,13b-hexahydro-2-methylpiperazino<1,2-a>thieno<2,3-c><1>benzazepine 1,2,3,4,10,13b-hexahydro-2-methylpiperazino<1,2-a>thieno<3,2-c><1>benzazepine 3-methyl-1,2,3,4,4a,5,6,7-octahydropyrazino<1,2-a>-1-benzazepine 3-β-(4-pyridylethyl)-1,2,3,4,4a,5,6,7-octahydropyrazino<1,2-a>-1-benzazepine 1,2,3,4,4a,5,6,7-octahydropyrazino<1,2-a>-1-benzazepine But-2-enedioic acid--2-methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine (1/1) Mirtazapine maleate, (R)- Mirtazapine hydrobromide 8-Hydroxymirtazapine, (S)- 8-Hydroxymirtazapine, (R)- Normirtazapine, (S)- 2-methyl-1,2,3,4,10,14b-hexahydro-benzo[c]pyrazino[1,2-a]pyrido[3,4-f]azepine 5-Methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene;pentahydrate 5-Methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene;dihydrate N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene 5-Methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene;tetrahydrate 2-[4-(2-Methylpropyl)phenyl]propanoic acid;5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene 5-Methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene;trihydrate (7R)-17-bromo-5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene (10aS)-1,2,3,4,6,7,8,10a-octahydropyrazino[1,2-a]azepine Mirtazapine-M (nor-HO-methoxy-) 2AC Mirtazapine-M (nor-HO-) 2AC Mirtazapine-M (nor-) AC 7,10-Dimethyl-1,2,3,4,8,9-hexahydropyrazino[1,2-a]azepine 6-Chloro-10-methyl-1,2,3,4,8,9-hexahydropyrazino[1,2-a]azepine (7R)-5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaen-6-one (10aR)-1,2,3,4,6,7,8,10a-octahydropyrazino[1,2-a]azepine Mirtazapine-M (HO-) AC ethene;(7S)-5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene [2-chloro-3-(trifluoromethyl)phenyl]-(10-methyl-6-pyrimidin-2-yl-3,4,8,9-tetrahydro-1H-pyrazino[1,2-a]azepin-2-yl)methanone (2-chloro-4-fluorophenyl)-(10-methyl-3,4,8,9-tetrahydro-1H-pyrazino[1,2-a]azepin-2-yl)methanone